TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biomérieux Sweden AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
347,692
|
327,479
|
311,163 |
| Financial expenses |
59
|
6
|
565 |
| Earnings before taxes |
9,321
|
5,434
|
4,059 |
| EBITDA |
11,440
|
7,022
|
7,542 |
| Total assets |
137,368
|
135,790
|
121,281 |
| Current assets |
127,446
|
124,509
|
108,157 |
| Current liabilities |
93,402
|
85,229
|
67,771 |
| Equity capital |
14,723
|
23,731
|
30,324 |
| - share capital |
500
|
500
|
500 |
| Employees (average) |
34
|
31
|
27 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
10.7%
|
17.5%
|
25.0% |
| Turnover per employee |
10,226
|
10,564
|
11,525 |
| Profit as a percentage of turnover |
2.7%
|
1.7%
|
1.3% |
| Return on assets (ROA) |
6.8%
|
4.0%
|
3.8% |
| Current ratio |
136.4%
|
146.1%
|
159.6% |
| Return on equity (ROE) |
63.3%
|
22.9%
|
13.4% |
| Change turnover |
20,213
|
16,316
|
-16,882 |
| Change turnover % |
6%
|
5%
|
-5% |
| Chg. No. of employees |
3
|
4
|
0 |
| Chg. No. of employees % |
10%
|
15%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.